<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1379" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1379/" /><meta name="ncbi_pagename" content="SYNE1 Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>SYNE1 Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="SYNE1 Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/12/06" /><meta name="citation_author" content="Marie Beaudin" /><meta name="citation_author" content="Pierre-Luc Gamache" /><meta name="citation_author" content="François Gros-Louis" /><meta name="citation_author" content="Nicolas Dupré" /><meta name="citation_pmid" content="20301553" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1379/" /><meta name="citation_keywords" content="SYNE1 Cerebellar Ataxia (Autosomal Recessive Cerebellar Ataxia 1 [ARCA1])" /><meta name="citation_keywords" content="SYNE1-Deficient Arthrogryposis Multiplex Congenita (AMC)" /><meta name="citation_keywords" content="Nesprin-1" /><meta name="citation_keywords" content="SYNE1" /><meta name="citation_keywords" content="SYNE1 Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="SYNE1 Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Marie Beaudin" /><meta name="DC.Contributor" content="Pierre-Luc Gamache" /><meta name="DC.Contributor" content="François Gros-Louis" /><meta name="DC.Contributor" content="Nicolas Dupré" /><meta name="DC.Date" content="2018/12/06" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1379/" /><meta name="description" content="SYNE1 deficiency comprises a phenotypic spectrum that ranges from autosomal recessive cerebellar ataxia at the mild end to arthrogryposis multiplex congenita (AMC) at the severe end. SYNE1-deficient cerebellar ataxia, the most commonly recognized manifestation of SYNE1 deficiency to date, is a slowly progressive disorder typically beginning in adulthood (age range 6-45 years). While some individuals have a pure cerebellar syndrome (i.e., cerebellar ataxia, dysarthria, dysmetria, abnormalities in ocular saccades and smooth pursuit), many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign) and/or lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations). Most patients develop features of the cerebellar cognitive and affective syndrome (i.e., significant deficits in attention, executive functioning, verbal working memory, and visuospatial/visuoconstructional skills). The two less common phenotypes are SYNE1-deficient childhood-onset multisystem disease (ataxia, upper and lower motor neuron dysfunction, muscle weakness and wasting, intellectual disability) and SYNE1-deficient arthrogryposis multiplex congenita (decreased fetal movements and severe neonatal hypotonia associated with multiple congenital joint contractures including clubfoot)." /><meta name="og:title" content="SYNE1 Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="SYNE1 deficiency comprises a phenotypic spectrum that ranges from autosomal recessive cerebellar ataxia at the mild end to arthrogryposis multiplex congenita (AMC) at the severe end. SYNE1-deficient cerebellar ataxia, the most commonly recognized manifestation of SYNE1 deficiency to date, is a slowly progressive disorder typically beginning in adulthood (age range 6-45 years). While some individuals have a pure cerebellar syndrome (i.e., cerebellar ataxia, dysarthria, dysmetria, abnormalities in ocular saccades and smooth pursuit), many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign) and/or lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations). Most patients develop features of the cerebellar cognitive and affective syndrome (i.e., significant deficits in attention, executive functioning, verbal working memory, and visuospatial/visuoconstructional skills). The two less common phenotypes are SYNE1-deficient childhood-onset multisystem disease (ataxia, upper and lower motor neuron dysfunction, muscle weakness and wasting, intellectual disability) and SYNE1-deficient arthrogryposis multiplex congenita (decreased fetal movements and severe neonatal hypotonia associated with multiple congenital joint contractures including clubfoot)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1379/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/syne1ca-ar/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1379/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88BDB0E04088D1000000000624024B.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1379_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1379_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/suclg1-mtddepl/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/syngap1-id/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1379_"><span class="title" itemprop="name">SYNE1 Deficiency</span></h1><p class="contrib-group"><span itemprop="author">Marie Beaudin</span>, MD, <span itemprop="author">Pierre-Luc Gamache</span>, MD, PhD, <span itemprop="author">Fran&#x000e7;ois Gros-Louis</span>, PhD, and <span itemprop="author">Nicolas Dupr&#x000e9;</span>, MD, MSc.</p><a data-jig="ncbitoggler" href="#__NBK1379_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1379_ai__"><div class="contrib half_rhythm"><span itemprop="author">Marie Beaudin</span>, MD<div class="affiliation small">CHU de Qu&#x000e9;bec<br />Department of Medicine<br />Faculty of Medicine<br />Universit&#x000e9; Laval<br />Qu&#x000e9;bec, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.lavalu@1.niduaeb.eiram" class="oemail">ac.lavalu@1.niduaeb.eiram</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Pierre-Luc Gamache</span>, MD, PhD<div class="affiliation small">CHU de Qu&#x000e9;bec<br />Department of Medicine<br />Faculty of Medicine<br />Universit&#x000e9; Laval<br />Qu&#x000e9;bec, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.lavalu@1.ehcamag.cul-erreip" class="oemail">ac.lavalu@1.ehcamag.cul-erreip</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Fran&#x000e7;ois Gros-Louis</span>, PhD<div class="affiliation small">Laval University Experimental Organogenesis Research Center/LOEX<br />Division of Regenerative Medicine<br />CHU de Qu&#x000e9;bec Research Center<br />Department of Surgery<br />Faculty of Medicine<br />Universit&#x000e9; Laval<br />Qu&#x000e9;bec, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.lavalu.demf@siuol-sorg.siocnarf" class="oemail">ac.lavalu.demf@siuol-sorg.siocnarf</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Nicolas Dupr&#x000e9;</span>, MD, MSc<div class="affiliation small">CHU de Qu&#x000e9;bec<br />Department of Medicine<br />Faculty of Medicine<br />Universit&#x000e9; Laval<br />Qu&#x000e9;bec, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.cq.vuog.ssss@ahc.erpud.salocin" class="oemail">ac.cq.vuog.ssss@ahc.erpud.salocin</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 23, 2007</span>; Last Update: <span itemprop="dateModified">December 6, 2018</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="syne1ca-ar.Summary" itemprop="description"><h2 id="_syne1ca-ar_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>SYNE1 deficiency comprises a phenotypic spectrum that ranges from <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> cerebellar ataxia at the mild end to arthrogryposis multiplex congenita (AMC) at the severe end. SYNE1-deficient cerebellar ataxia, the most commonly recognized manifestation of SYNE1 deficiency to date, is a slowly progressive disorder typically beginning in adulthood (age range 6-45 years). While some individuals have a pure cerebellar syndrome (i.e., cerebellar ataxia, dysarthria, dysmetria, abnormalities in ocular saccades and smooth pursuit), many also have upper motor neuron dysfunction (spasticity, hyperreflexia, Babinski sign) and/or lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations). Most patients develop features of the cerebellar cognitive and affective syndrome (i.e., significant deficits in attention, executive functioning, verbal working memory, and visuospatial/visuoconstructional skills). The two less common phenotypes are SYNE1-deficient childhood-onset multisystem disease (ataxia, upper and lower motor neuron dysfunction, muscle weakness and wasting, intellectual disability) and SYNE1-deficient arthrogryposis multiplex congenita (decreased fetal movements and severe neonatal hypotonia associated with multiple <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> joint contractures including clubfoot).</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of SYNE1 deficiency is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive findings and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SYNE1</i> pathogenic variants identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> There is no specific treatment for SYNE1 deficiency. The goals of treatment are to maximize function and reduce complications. Each patient should be managed by a multidisciplinary team of relevant specialists including neurologists, occupational therapists, physical therapists, physiatrists, orthopedists, nutritionists, speech therapists, respiratory therapists, and psychologists depending on the clinical manifestations.</p><p><i>Surveillance:</i> Annual (or more often as needed) neurologic examination; assessment of mobility and self-help skills (as they relate to ataxia, spasticity, weakness), dysarthria, dysphagia, cognition, and psychiatric manifestations.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>SYNE1 deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>SYNE1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>). At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Once the <i>SYNE1</i> pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="syne1ca-ar.GeneReview_Scope"><h2 id="_syne1ca-ar_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="syne1ca-ar.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1379/table/syne1ca-ar.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__syne1ca-ar.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_syne1ca-ar.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SYNE1 Deficiency: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_syne1ca-ar.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div><i>SYNE1</i> cerebellar ataxia (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> cerebellar ataxia 1 [ARCA1])</div></li><li class="half_rhythm"><div>SYNE1-deficient arthrogryposis multiplex congenita (AMC)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#syne1ca-ar.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="syne1ca-ar.TF.d.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#syne1ca-ar.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="syne1ca-ar.Diagnosis"><h2 id="_syne1ca-ar_Diagnosis_">Diagnosis</h2><p>SYNE1 deficiency comprises a phenotypic spectrum that ranges from <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> cerebellar ataxia to arthrogryposis multiplex congenita (AMC).</p><div id="syne1ca-ar.Suggestive_Findings"><h3>Suggestive Findings</h3><p>SYNE1 deficiency <b>should be suspected</b> in individuals with a combination of the following clinical features and/or clinical syndrome based on age of onset.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div>Cerebellar ataxia</div><ul><li class="half_rhythm"><div>Progressive ataxia of gait</div></li><li class="half_rhythm"><div>Clumsiness of hands</div></li><li class="half_rhythm"><div>Dysmetria</div></li><li class="half_rhythm"><div>Dysarthria</div></li><li class="half_rhythm"><div>Abnormalities in ocular saccades and smooth pursuit</div></li></ul></li><li class="half_rhythm"><div>Upper and/or lower motor neuron involvement</div><ul><li class="half_rhythm"><div>Spasticity, hyperactive deep tendon reflexes, extensor plantar response</div></li><li class="half_rhythm"><div>Muscle atrophy, diminished deep tendon reflexes, fasciculations</div></li></ul></li><li class="half_rhythm"><div>Cognitive impairment</div><ul><li class="half_rhythm"><div>Delayed motor milestones in infancy</div></li><li class="half_rhythm"><div>Intellectual disability</div></li><li class="half_rhythm"><div>Cognitive dysfunction typical of the cerebellar cognitive and affective syndrome (deficits in executive functioning, language, visuospatial/visuoconstructional skills)</div></li></ul></li><li class="half_rhythm"><div>Skeletal involvement</div><ul><li class="half_rhythm"><div>Scoliosis or kyphosis</div></li><li class="half_rhythm"><div><i>Pes cavus</i></div></li><li class="half_rhythm"><div>Arthrogryposis with distal joint contractures</div></li></ul></li></ul><p><b>Clinical syndrome,</b> defined according to age at onset:</p><ul><li class="half_rhythm"><div><b>Neonatal onset.</b> Arthrogryposis multiplex congenita (AMC); neonatal hypotonia with decreased fetal movements resulting in distal joint contractures (including bilateral clubfoot, adducted thumbs, flexion contractures of fingers) followed by delayed motor milestones and progressive motor decline after the first decade [<a class="bk_pop" href="#syne1ca-ar.REF.attali.2009.3462">Attali et al 2009</a>, <a class="bk_pop" href="#syne1ca-ar.REF.baumann.2017.262">Baumann et al 2017</a>]</div></li><li class="half_rhythm"><div><b>Childhood onset.</b> Multisystem <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>; childhood-onset ataxia with upper and lower motor neuron dysfunction, elevation of serum CK concentration, <i>pes cavus</i>, other skeletal and soft tissue anomalies, intellectual disability, followed by respiratory insufficiency in adolescence [<a class="bk_pop" href="#syne1ca-ar.REF.synofzik.2017.332">Synofzik &#x00026; Sch&#x000fc;le 2017</a>]</div></li><li class="half_rhythm"><div><b>Adult onset.</b> Cerebellar ataxia (ARCA1); cerebellar ataxia, frequent upper and/or lower motor neuron involvement, and cognitive impairment typical of the cerebellar cognitive and affective syndrome [<a class="bk_pop" href="#syne1ca-ar.REF.dupr_.2007.93">Dupr&#x000e9; et al 2007</a>, <a class="bk_pop" href="#syne1ca-ar.REF.synofzik.2016.1378">Synofzik et al 2016</a>]</div></li></ul></div><div id="syne1ca-ar.Electrophysiologic_Studies"><h3>Electrophysiologic Studies</h3><p><b>Cerebellar ataxia</b></p><ul><li class="half_rhythm"><div><b>Nerve conduction studies.</b> Usually normal; may occasionally show an axonal neuropathy [<a class="bk_pop" href="#syne1ca-ar.REF.synofzik.2016.1378">Synofzik et al 2016</a>, <a class="bk_pop" href="#syne1ca-ar.REF.yucesan.2017.2203">Yucesan et al 2017</a>]</div></li><li class="half_rhythm"><div><b>Electromyography (EMG).</b> Usually normal; may occasionally show acute or chronic neurogenic changes in individuals with clinical evidence of motor neuron dysfunction [<a class="bk_pop" href="#syne1ca-ar.REF.izumi.2013.600">Izumi et al 2013</a>, <a class="bk_pop" href="#syne1ca-ar.REF.synofzik.2016.1378">Synofzik et al 2016</a>]</div></li></ul><p><b>AMC</b></p><ul><li class="half_rhythm"><div><b>Nerve conduction studies and EMG (in newborns).</b> May be normal [<a class="bk_pop" href="#syne1ca-ar.REF.baumann.2017.262">Baumann et al 2017</a>]</div></li><li class="half_rhythm"><div><b>EMG (later onset).</b> Includes mild chronic neurogenic findings [<a class="bk_pop" href="#syne1ca-ar.REF.attali.2009.3462">Attali et al 2009</a>]</div></li></ul></div><div id="syne1ca-ar.Brain_Imaging"><h3>Brain Imaging</h3><p>Brain MRI in patients with childhood-onset multisystem disease or adult-onset ataxia usually shows marked diffuse cerebellar atrophy with no other abnormalities (<a class="figpopup" href="/books/NBK1379/figure/syne1ca-ar.F1/?report=objectonly" target="object" rid-figpopup="figsyne1caarF1" rid-ob="figobsyne1caarF1">Figure 1</a>).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figsyne1caarF1" co-legend-rid="figlgndsyne1caarF1"><a href="/books/NBK1379/figure/syne1ca-ar.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figsyne1caarF1" rid-ob="figobsyne1caarF1"><img class="small-thumb" src="/books/NBK1379/bin/syne1ca-ar-Image001.gif" src-large="/books/NBK1379/bin/syne1ca-ar-Image001.jpg" alt="Figure 1. . MRI of a female age 29 years with SYNE1 adult-onset cerebellar ataxia." /></a><div class="icnblk_cntnt" id="figlgndsyne1caarF1"><h4 id="syne1ca-ar.F1"><a href="/books/NBK1379/figure/syne1ca-ar.F1/?report=objectonly" target="object" rid-ob="figobsyne1caarF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">MRI of a female age 29 years with <i>SYNE1</i> adult-onset cerebellar ataxia. Sagittal T<sub>1</sub>-weighted imaging shows marked diffuse cerebellar atrophy with no atrophy of the cerebral cortex, midbrain, pons, or medulla. </p></div></div><ul><li class="half_rhythm"><div>Brain stem atrophy has been reported in one individual with childhood-onset multisystem disease [<a class="bk_pop" href="#syne1ca-ar.REF.izumi.2013.600">Izumi et al 2013</a>].</div></li><li class="half_rhythm"><div>White matter abnormalities in the brain and spinal cord that mimicked findings in multiple sclerosis have been reported in two individuals with adult-onset ataxia [<a class="bk_pop" href="#syne1ca-ar.REF.algahtani.2017.97">Algahtani et al 2017</a>].</div></li></ul><p><sup>18</sup>F-FDG-PET imaging shows marked homogeneous hypometabolism in the cerebellar hemispheres. Pontine brain stem hypometabolism has been reported in one individual with motor neuron involvement [<a class="bk_pop" href="#syne1ca-ar.REF.synofzik.2016.1378">Synofzik et al 2016</a>].</p></div><div id="syne1ca-ar.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of SYNE1 deficiency <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive findings and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SYNE1</i> pathogenic variants identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1379/table/syne1ca-ar.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="figsyne1caarTmoleculargenetictestingu" rid-ob="figobsyne1caarTmoleculargenetictestingu">Table 1</a>).</p><p>Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of SYNE1 deficiency is indistinguishable from many other inherited disorders with similar complex neurologic and neuromuscular phenotypes, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches include <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> [<a class="bk_pop" href="#syne1ca-ar.REF.dupr_.2007.93">Dupr&#x000e9; et al 2007</a>, <a class="bk_pop" href="#syne1ca-ar.REF.baumann.2017.262">Baumann et al 2017</a>, <a class="bk_pop" href="#syne1ca-ar.REF.coutelier.2018.591">Coutelier et al 2018</a>, <a class="bk_pop" href="#syne1ca-ar.REF.sun.2018">Sun et al 2018</a>].</p><p>Note: Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>SYNE1</i>, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>) is rarely useful and typically NOT recommended.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible. If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SYNE1</i> and other genes of interest (see <a href="#syne1ca-ar.Differential_Diagnosis">Differential Diagnosis</a>) may be considered to identify the genetic cause of the condition at a reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="syne1ca-ar.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in SYNE1 Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1379/table/syne1ca-ar.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__syne1ca-ar.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_syne1ca-ar.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_syne1ca-ar.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_syne1ca-ar.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_syne1ca-ar.T.molecular_genetic_testing_u_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SYNE1</i></td><td headers="hd_h_syne1ca-ar.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_syne1ca-ar.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_syne1ca-ar.T.molecular_genetic_testing_u_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_syne1ca-ar.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown (no data on <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted del/dup analysis are available)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="syne1ca-ar.TF.1.1"><p class="no_margin">See <a href="/books/NBK1379/#syne1ca-ar.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="syne1ca-ar.TF.1.2"><p class="no_margin">See <a href="#syne1ca-ar.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="syne1ca-ar.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="syne1ca-ar.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#syne1ca-ar.REF.dupr_.2007.93">Dupr&#x000e9; et al [2007]</a>, <a class="bk_pop" href="#syne1ca-ar.REF.mademan.2016.e46">Mademan et al [2016]</a>, <a class="bk_pop" href="#syne1ca-ar.REF.synofzik.2016.1378">Synofzik et al [2016]</a>, <a class="bk_pop" href="#syne1ca-ar.REF.baumann.2017.262">Baumann et al [2017]</a>, <a class="bk_pop" href="#syne1ca-ar.REF.coutelier.2018.591">Coutelier et al [2018]</a>, <a class="bk_pop" href="#syne1ca-ar.REF.sun.2018">Sun et al [2018]</a></p></div></dd><dt>5. </dt><dd><div id="syne1ca-ar.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div><div id="syne1ca-ar.Clinical_Characteristics"><h2 id="_syne1ca-ar_Clinical_Characteristics_">Clinical Characteristics</h2><div id="syne1ca-ar.Clinical_Description"><h3>Clinical Description</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> and severity of SYNE1 deficiency vary widely and span a spectrum ranging from adult-onset cerebellar ataxia at the milder end to childhood-onset multisystem disease and prenatal-onset arthrogryposis multiplex congenita at the more severe end.</p><div id="syne1ca-ar.SYNE1_AdultOnset_Cerebellar_A"><h4><i>SYNE1</i> Adult-Onset Cerebellar Ataxia</h4><p>SYNE1-deficient cerebellar ataxia, also known as <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> cerebellar ataxia 1 (ARCA1), typically begins in adulthood (mean age at onset: 31.6 years [<a class="bk_pop" href="#syne1ca-ar.REF.dupr_.2007.93">Dupr&#x000e9; et al 2007</a>]; range 6 to 45 years in reported series).</p><p>The initial description of ARCA1 was that of a pure cerebellar syndrome characterized by cerebellar ataxia, dysarthria, dysmetria, and abnormalities in ocular saccades and smooth pursuit [<a class="bk_pop" href="#syne1ca-ar.REF.dupr_.2007.93">Dupr&#x000e9; et al 2007</a>]. In patients from the original series, 33% had brisk reflexes and 6% had positive Babinski signs and/or ankle clonus, suggesting mild upper motor neuron involvement. Subsequently, <a class="bk_pop" href="#syne1ca-ar.REF.synofzik.2016.1378">Synofzik et al [2016]</a> reported motor neuron dysfunction in as many as 58% of patients, comprising 31% with pure upper motor neuron dysfunction (spasticity, positive bilateral Babinski signs), 19% with combined upper and lower motor neuron dysfunction, and 8% with pure lower motor neuron dysfunction (amyotrophy, reduced reflexes, fasciculations, or neurogenic changes on EMG). Slow saccades have been reported along with other oculomotor abnormalities, including square wave jerks, ophthalmoparesis, and strabismus. Skeletal involvement with scoliosis and <i>pes cavus</i> is an associated finding in some patients. Reduced sense of vibration, polyneuropathy, and urge incontinence are rare occurrences [<a class="bk_pop" href="#syne1ca-ar.REF.synofzik.2016.1378">Synofzik et al 2016</a>]. There is no evidence of muscle disease, and creatine kinase values are normal.</p><p>Individuals with SYNE1-deficient cerebellar ataxia show typical findings of the cerebellar cognitive and affective syndrome: significant deficits in attention, executive functioning, verbal working memory, and visuospatial/visuoconstructional skills [<a class="bk_pop" href="#syne1ca-ar.REF.laforce.2010.443">Laforce et al 2010</a>, <a class="bk_pop" href="#syne1ca-ar.REF.mademan.2016.e46">Mademan et al 2016</a>].</p><p>The disease course is usually slowly progressive, resulting in a moderate degree of disability but normal life expectancy [<a class="bk_pop" href="#syne1ca-ar.REF.dupr_.2007.93">Dupr&#x000e9; et al 2007</a>].</p></div><div id="syne1ca-ar.SYNE1_ChildhoodOnset_Multisys"><h4><i>SYNE1</i> Childhood-Onset Multisystem Disease</h4><p>A rarer <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is childhood-onset complex and severe multisystem disease with ataxia, upper and lower motor neuron dysfunction, <i>pes cavus</i>, intellectual disability, and findings suggestive of muscle disease (weakness, muscle wasting, elevated creatine kinase values, respiratory insufficiency) [<a class="bk_pop" href="#syne1ca-ar.REF.synofzik.2016.1378">Synofzik et al 2016</a>]. Involvement of bulbar muscles may be prominent with tongue fasciculations and atrophy as well as slurred speech, and the clinical picture may mimic amyotrophic lateral sclerosis [<a class="bk_pop" href="#syne1ca-ar.REF.izumi.2013.600">Izumi et al 2013</a>]. Respiratory insufficiency may present with respiratory distress or restrictive lung disease and may require noninvasive or mechanical ventilation. The reported broad range of skeletal and soft tissue abnormalities includes sacral cysts, pseudoarthrosis clavicula, hyperlaxity of joints, Achilles tendon contractures, kyphosis, scoliosis, <i>pes cavus</i>, cataract, and hypertelorism.</p><p>One individual had developmental abnormalities of the visceral organs (i.e., malrotation of the colon and unilateral position of both kidneys) [<a class="bk_pop" href="#syne1ca-ar.REF.mademan.2016.e46">Mademan et al 2016</a>, <a class="bk_pop" href="#syne1ca-ar.REF.synofzik.2016.1378">Synofzik et al 2016</a>].</p><p>Brain MRI may show brain stem atrophy in addition to cerebellar atrophy [<a class="bk_pop" href="#syne1ca-ar.REF.izumi.2013.600">Izumi et al 2013</a>].</p><p>Death between ages 36 and 44 years has been reported in a few individuals [<a class="bk_pop" href="#syne1ca-ar.REF.izumi.2013.600">Izumi et al 2013</a>, <a class="bk_pop" href="#syne1ca-ar.REF.synofzik.2016.1378">Synofzik et al 2016</a>].</p></div><div id="syne1ca-ar.SYNE1_Arthrogryposis_Multiple"><h4><i>SYNE1</i> Arthrogryposis Multiplex Congenita</h4><p>SYNE1-deficient arthrogryposis multiplex congenita is characterized by decreased fetal movements in the absence of polyhydramnios, intrauterine growth restriction, or associated malformations [<a class="bk_pop" href="#syne1ca-ar.REF.attali.2009.3462">Attali et al 2009</a>, <a class="bk_pop" href="#syne1ca-ar.REF.baumann.2017.262">Baumann et al 2017</a>]. Neonates have severe hypotonia presenting as "floppy infant" with bilateral clubfeet, distal joint contractures with adducted thumbs and flexion contractures of fingers, and cryptorchidism in males [see <a href="https://www.nature.com/articles/ejhg2016144" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Baumann et al 2017</a>, Figure 1]. Proximal weakness, facial weakness, and decreased or absent deep tendon reflexes have been reported. Motor milestones are delayed, followed by progressive motor decline after the first decade. Patients use the Gower maneuver when arising from a squatting position and have limited ability to ambulate independently and to alternate their feet when climbing stairs. Flexion contractures of the proximal interphalangeal joints of the third and fourth fingers may persist despite adequate management.</p><p>Cerebellar involvement and pyramidal signs have not been reported. Intellectual development is borderline to normal. Growth deficiency worsens with advancing age despite adequate weight gain. Hyperopia with intermittent strabismus has been reported.</p><p>Early death has been reported in two individuals: one age 22 years with severe kyphoscoliosis and restrictive lung disease who died of pneumonia and sepsis [<a class="bk_pop" href="#syne1ca-ar.REF.attali.2009.3462">Attali et al 2009</a>], and an infant age four months who presented with severe neonatal hypotonia and respiratory failure. Note that the infant did not undergo genetic testing but had a sib with confirmed SYNE1 deficiency [<a class="bk_pop" href="#syne1ca-ar.REF.baumann.2017.262">Baumann et al 2017</a>].</p><p>In SYNE1-deficient AMC, muscle biopsy may show variations in the size of muscle fibers without increased number of muscle fibers with central nuclei. Creatine kinase values are normal.</p></div></div><div id="syne1ca-ar.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>Most pathogenic variants associated with the ARCA1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> are <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> or frameshift and are localized throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, excluding the KASH <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. Most &#x02013; but not all &#x02013; <i>SYNE1</i> pathogenic variants associated with motor neuron involvement are located toward the 3' end of the gene [<a class="bk_pop" href="#syne1ca-ar.REF.yoshinaga.2017.17052">Yoshinaga et al 2017</a>].</p><p><i>SYNE1</i> pathogenic variants associated with arthrogryposis multiplex congenita (AMC) are distal truncating variants that are expected to lead to a truncated Nesprin1&#x003b1; (or Nesprin1&#x003b1;2) isoform, which is muscle and retina specific [<a class="bk_pop" href="#syne1ca-ar.REF.duong.2014.e94380">Duong et al 2014</a>, <a class="bk_pop" href="#syne1ca-ar.REF.potter.2017">Potter et al 2017</a>].</p></div><div id="syne1ca-ar.Nomenclature"><h3>Nomenclature</h3><p>In this <i>GeneReview</i>, the term "SYNE1 deficiency" refers to the full neurologic and neuromuscular phenotypic spectrum of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SYNE1</i> pathogenic variants: from <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> cerebellar ataxia 1 (ARCA1) at the mild end of the continuum to SYNE1-AMC at the most severe end of the continuum.</p><p>Note: Autosomal recessive cerebellar ataxia 1 (ARCA1) has also been referred to as "recessive ataxia of Beauce" and "spinocerebellar ataxia recessive 8" (SCAR8).</p><p>Most recently, the International Parkinson and Movement Disorder Society Task Force on Classification and Nomenclature of Genetic Movement Disorders suggested the term "ATX-SYNE1" [<a class="bk_pop" href="#syne1ca-ar.REF.rossi.2018.1056">Rossi et al 2018</a>].</p></div><div id="syne1ca-ar.Prevalence"><h3>Prevalence</h3><p>ARCA1, initially described in the French Canadian population, has now been reported worldwide, notably in Japan, Europe, the Middle East, and Brazil. Although its exact prevalence is not known, it is highly prevalent in the French Canadian population, which is a homogeneous founder population [<a class="bk_pop" href="#syne1ca-ar.REF.dupr_.2007.93">Dupr&#x000e9; et al 2007</a>].</p><p>When Friedreich ataxia has been excluded, SYNE1 deficiency represents 5.3%-6% of unexplained early-onset (i.e., age &#x0003c;40 years) <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> ataxias [<a class="bk_pop" href="#syne1ca-ar.REF.mademan.2016.e46">Mademan et al 2016</a>, <a class="bk_pop" href="#syne1ca-ar.REF.synofzik.2016.1378">Synofzik et al 2016</a>].</p><p>The prevalence of SYNE1-deficient arthrogryposis multiplex congenita cannot be evaluated as it has only been reported in a few families to date.</p></div></div><div id="syne1ca-ar.Genetically_Related_Allelic_D"><h2 id="_syne1ca-ar_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>Heterozygous <i>SYNE1</i> pathogenic variants are also an uncommon cause of Emery-Dreifuss muscular dystrophy type 4 (EDMD4) or Emery-Dreifuss muscular dystrophy-like, characterized by early joint contractures, progressive muscular atrophy, and muscle weakness, with cardiomyopathy in EDMD [<a class="bk_pop" href="#syne1ca-ar.REF.zhang.2007.2816">Zhang et al 2007</a>] or without cardiac involvement in EDMD-like [<a class="bk_pop" href="#syne1ca-ar.REF.chen.2017.63">Chen et al 2017</a>]. Typically, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals manifest the following: (1) early contractures of the Achilles tendons, elbows, and posterior cervical muscles (progression of which eventually severely limits anterior spinal flexion); (2) progressive skeletal muscle weakness and wasting; and (3) severe cardiomyopathy with ventricular and supraventricular arrhythmias, chamber dilatation, and heart failure as a consequence of myocardial cell replacement by fibrosis and adipose tissue [<a class="bk_pop" href="#syne1ca-ar.REF.chen.2017.63">Chen et al 2017</a>]. Heart transplantation may be required.</p></div><div id="syne1ca-ar.Differential_Diagnosis"><h2 id="_syne1ca-ar_Differential_Diagnosis_">Differential Diagnosis</h2><div id="syne1ca-ar.T.disorders_to_consider_in_th" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of SYNE1 Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1379/table/syne1ca-ar.T.disorders_to_consider_in_th/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__syne1ca-ar.T.disorders_to_consider_in_th_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_2" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_3" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4" id="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/SYNE1 Deficiency</th><th headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4" id="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from SYNE1 Deficiency</th></tr></thead><tbody><tr><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SCA-AR, 10 (SCAR10; ARCA3)<br />(see <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>)</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ANO10</i></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Very similar clinically</div></li><li class="half_rhythm"><div>Pure cerebellar ataxia w/occasional UMN signs</div></li><li class="half_rhythm"><div>Cognitive impairment</div></li><li class="half_rhythm"><div>Absence of polyneuropathy</div></li><li class="half_rhythm"><div>Marked cerebellar atrophy</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Seen mainly in Europe (whereas SYNE1 deficiency is seen worldwide)</td></tr><tr><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/coq10-def/">Primary coenzyme Q<sub>10</sub> deficiency</a><br />(SCAR9; ARCA2)</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COQ8A</i></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Often a pure cerebellar ataxia <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> w/cognitive impairment &#x00026; cerebellar atrophy</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Exercise intolerance</div></li><li class="half_rhythm"><div>Epilepsy</div></li><li class="half_rhythm"><div>Myoclonus</div></li><li class="half_rhythm"><div>Occasional stroke-like cerebral lesions</div></li><li class="half_rhythm"><div>Absence of UMN &#x00026;/or LMN signs</div></li></ul>
</td></tr><tr><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/friedreich/">Friedreich ataxia</a></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FXN</i></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cerebellar ataxia</div></li><li class="half_rhythm"><div>Positive Babinski signs</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Sensory involvement w/spinal cord atrophy</div></li><li class="half_rhythm"><div>Abolished reflexes</div></li><li class="half_rhythm"><div>Square-wave jerks</div></li><li class="half_rhythm"><div>Hypertrophic cardiomyopathy</div></li><li class="half_rhythm"><div>Childhood to teenage onset</div></li><li class="half_rhythm"><div>Absence of cerebellar atrophy</div></li></ul>
</td></tr><tr><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Boucher-Neuh&#x000e4;user syndrome &#x00026; <i>PNPLA6</i>-related Gordon Holmes syndrome<br />(see <a href="/books/n/gene/pnpla6-dis/"><i>PNPLA6</i>-Related Disorders</a>)</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PNPLA6</i></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cerebellar ataxia</div></li><li class="half_rhythm"><div>Spasticity</div></li><li class="half_rhythm"><div>Hyperreflexia</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Hypogonadotropic hypogonadism</div></li><li class="half_rhythm"><div>Chorioretinal dystrophy</div></li><li class="half_rhythm"><div>Childhood onset</div></li><li class="half_rhythm"><div>Pontine atrophy</div></li></ul>
</td></tr><tr><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/arsacs/">ARSACS</a><br />(AR spastic ataxia of Charlevoix-Saguenay)</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SACS</i></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Ataxia</div></li><li class="half_rhythm"><div>Dysarthria</div></li><li class="half_rhythm"><div>Eye movement abnormalities</div></li><li class="half_rhythm"><div>UMN signs</div></li><li class="half_rhythm"><div>Seen worldwide but high prevalence in French Canadians</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Infantile or childhood onset</div></li><li class="half_rhythm"><div>Sensorimotor neuropathy</div></li><li class="half_rhythm"><div>Retinal striation</div></li><li class="half_rhythm"><div>Frequent mitral valve prolapse</div></li></ul>
</td></tr><tr><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/spg7/">Spastic paraplegia 7</a></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SPG7</i></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Pyramidal signs w/spasticity</div></li><li class="half_rhythm"><div>Cerebellar ataxia w/cerebellar atrophy</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Spastic paraparesis more predominant</div></li><li class="half_rhythm"><div>Optic neuropathy</div></li><li class="half_rhythm"><div>Ptosis</div></li></ul>
</td></tr><tr><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sca3/">SCA3</a></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATXN3</i></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cerebellar ataxia</div></li><li class="half_rhythm"><div>UMN signs w/occasional amyotrophy &#x00026; fasciculations</div></li><li class="half_rhythm"><div>Cognitive impairment</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Extrapyramidal features w/dystonia, rigidity, parkinsonism</div></li><li class="half_rhythm"><div>Progressive external ophthalmoparesis</div></li></ul>
</td></tr><tr><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sca6/">SCA6</a></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CACNA1A</i></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cerebellar ataxia w/adult onset &#x00026; slow progression</div></li><li class="half_rhythm"><div>Occasional UMN signs</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Extrapyramidal features w/dystonia &#x00026; blepharospasm</td></tr><tr><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fragile X-associated tremor / ataxia syndrome (FXTAS) (see <a href="/books/n/gene/fragilex/"><i>FMR1</i>-Related Disorders</a>)</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FMR1</i></td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cerebellar ataxia of adult onset</div></li><li class="half_rhythm"><div>Cognitive impairment</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_1_4 hd_h_syne1ca-ar.T.disorders_to_consider_in_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Predominant tremor</div></li><li class="half_rhythm"><div>Parkinsonism</div></li><li class="half_rhythm"><div>MRI: White matter lesions in cerebellar peduncles &#x00026; brain stem</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; LMN = lower motor neuron; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; SCA = spinocerebellar ataxia; UMN = upper motor neuron; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="syne1ca-ar.TF.2.1"><p class="no_margin">Within a MOI, genes are in alphabetic order.</p></div></dd></dl></div></div></div></div><div id="syne1ca-ar.Management"><h2 id="_syne1ca-ar_Management_">Management</h2><div id="syne1ca-ar.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with SYNE1 deficiency, the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><div id="syne1ca-ar.T.recommended_evaluations_fol" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with SYNE1-Deficient Cerebellar Ataxia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1379/table/syne1ca-ar.T.recommended_evaluations_fol/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__syne1ca-ar.T.recommended_evaluations_fol_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System</th><th id="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Assessment by neurologist for:
<ul><li class="half_rhythm"><div>Cerebellar motor dysfunction (gait &#x00026; postural ataxia, dysmetria, dysdiadochokinesis, tremor, dysarthria, nystagmus, saccades &#x00026; smooth pursuit)</div></li><li class="half_rhythm"><div>UMN &#x00026;/or LMN dysfunction (weakness, spasticity, Babinski signs, hyperrefflexia, amyotrophy, fasciculations)</div></li><li class="half_rhythm"><div>Vibration loss or polyneuropathy based on clinical findings</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Use standardized scale to establish baseline for ataxia (SARA, ICARS, or BARS).&#x000a0;<sup>1,&#x000a0;2</sup></td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_3" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consider electrophysiologic studies (EMG &#x00026; NCS) to detect neurogenic changes or signs of neuropathy.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_3" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Brain MRI to evaluate presence &#x00026; severity of cerebellar atrophy</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Refer to neuromuscular clinic (OT/PT/rehabilitation specialist).</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To assess gross motor &#x00026; fine motor skills, ambulation, &#x00026; need for adaptive devices &#x00026; PT</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Speech</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For those w/dysarthria: speech/language evaluation</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For those w/frequent choking or severe dysphagia, assess:
<ul><li class="half_rhythm"><div>Nutritional status</div></li><li class="half_rhythm"><div>Aspiration risk</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider involving a gastroenterology/nutrition/feeding team.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For those w/respiratory symptoms or muscular involvement: obtain pulmonary function tests</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider involving pulmonary specialist / respiratory therapist</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cognitive/</b><br /><b>Psychiatric</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for cognitive dysfunction assoc w/cerebellar cognitive &#x00026; affective syndrome (executive function, language processing, visuospatial/visuoconstructional skills, emotion regulation)</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider use of:
<ul><li class="half_rhythm"><div>CCAS scale&#x000a0;<sup>3</sup> to evaluate cognitive &#x00026; emotional involvement</div></li><li class="half_rhythm"><div>Psychiatrist, psychologist, neuropsychologist if needed</div></li></ul>
</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for skeletal involvement, mainly scoliosis &#x00026; <i>pes cavus.</i></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">EMG = electromyogram; LMN = lower motor neuron; NCS = nerve conduction study; OT = occupational therapy; PT = physical therapy; UMN = upper motor neuron</p></div></dd><dt>1. </dt><dd><div id="syne1ca-ar.TF.3.1"><p class="no_margin">SARA = Scale for the Assessment and Rating of Ataxia; ICARS = International Co-operative Ataxia Rating Scale; BARS = Brief Ataxia Rating Scale</p></div></dd><dt>2. </dt><dd><div id="syne1ca-ar.TF.3.2"><p class="no_margin"><a class="bk_pop" href="#syne1ca-ar.REF.b_rk.2018.329">B&#x000fc;rk &#x00026; Sival [2018]</a></p></div></dd><dt>3. </dt><dd><div id="syne1ca-ar.TF.3.3"><p class="no_margin"><a class="bk_pop" href="#syne1ca-ar.REF.hoche.2018.248">Hoche et al [2018]</a></p></div></dd></dl></div></div></div><div id="syne1ca-ar.T.recommended_evaluations_fol_1" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with SYNE1-Deficient Arthrogryposis Multiplex Congenita</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1379/table/syne1ca-ar.T.recommended_evaluations_fol_1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__syne1ca-ar.T.recommended_evaluations_fol_1_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System</th><th id="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment by neurologist of:
<ul><li class="half_rhythm"><div>Tone, primitive reflexes, deep tendon reflexes</div></li><li class="half_rhythm"><div>Progression of motor milestones</div></li><li class="half_rhythm"><div>Muscular involvement (e.g., proximal weakness, facial weakness)</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider EMG, which may show neurogenic changes.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multidisciplinary neuromuscular clinic assessment by orthopedist, physiatrist, OT/PT</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To include assessment of:
<ul><li class="half_rhythm"><div>Gross motor &#x00026; fine motor skills</div></li><li class="half_rhythm"><div>Contractures, clubfoot, &#x00026; kyphoscoliosis</div></li><li class="half_rhythm"><div>Need for adaptive devices</div></li><li class="half_rhythm"><div>Need for PT (for improving gross motor skills) &#x00026;/or OT (for improving fine motor skills)</div></li></ul>
</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess:
<ul><li class="half_rhythm"><div>Nutritional status</div></li><li class="half_rhythm"><div>Aspiration risk</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider involving:
<ul><li class="half_rhythm"><div>Gastroenterologist</div></li><li class="half_rhythm"><div>Nutritionist</div></li><li class="half_rhythm"><div>Feeding team</div></li></ul>
</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Speech</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Speech/language evaluation</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Involve pulmonary specialist / respiratory therapist</div></li><li class="half_rhythm"><div>Assess for pulmonary insufficiency</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurodevelopmental</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>To include motor, speech/language evaluation, &#x00026; general cognitive skills</div></li><li class="half_rhythm"><div>Evaluation for early intervention / special education</div></li></ul>
</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_syne1ca-ar.T.recommended_evaluations_fol_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">OT = occupational therapy/therapist; PT = physical therapy/therapist</p></div></dd><dt>1. </dt><dd><div id="syne1ca-ar.TF.4.1"><p class="no_margin"><a class="bk_pop" href="#syne1ca-ar.REF.baumann.2017.262">Baumann et al [2017]</a></p></div></dd></dl></div></div></div></div><div id="syne1ca-ar.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>There is no specific treatment for SYNE1 deficiency. The goals of treatment are to maximize function and reduce complications. Each patient should be managed by a multidisciplinary team of relevant specialists such as neurologists, occupational therapists (OT), physical therapists (PT), physiatrists, orthopedists, nutritionists, speech therapists, respiratory therapists, and psychologists depending on the clinical manifestations.</p><div id="syne1ca-ar.T.treatment_of_manifestations" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with SYNE1-Deficient Cerebellar Ataxia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1379/table/syne1ca-ar.T.treatment_of_manifestations/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__syne1ca-ar.T.treatment_of_manifestations_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation</th><th id="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ataxia</b></td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Care by physiatrist, OT/PT</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Consider adaptive devices to maintain/improve independence in mobility (e.g., canes, walkers, ramps to accommodate motorized chairs), feeding (e.g., weighted eating utensils), dressing (e.g., dressing hooks)</div></li><li class="half_rhythm"><div>PT (balance exercises, gait training, muscle strengthening) to maintain mobility &#x00026; function&#x000a0;<sup>1</sup></div></li><li class="half_rhythm"><div>OT to optimize ADL</div></li><li class="half_rhythm"><div>Inpatient rehabilitation w/OT/PT may improve ataxia &#x00026; functional abilities in patients w/degenerative ataxias.&#x000a0;<sup>2,&#x000a0;3</sup></div></li><li class="half_rhythm"><div>Weight control to avoid obesity</div></li><li class="half_rhythm"><div>Home adaptations to prevent falls (e.g., grab bars, raised toilet seats)</div></li></ul>
</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Pharmacologic treatment</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider Riluzole (100 mg/d&#x000a0;<sup>3</sup>), the only drug shown to improve ataxia symptoms in persons w/ataxia of mixed etiologies; use requires monitoring of liver enzymes.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Transcranial magnetic stimulation</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider transcranial magnetic stimulation over the cerebellum,&#x000a0;<sup>2</sup> which possibly improves cerebellar motor signs after 21 daily treatments (tested in patients w/various causes of spinocerebellar degeneration).</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Upper motor neuron involvement (spasticity)</b></td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pharmacologic treatment</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Baclofen, tizanidine, or dantrolene may relieve muscle spasms &#x00026; spasticity; however, there are no specific guidelines for SYNE1 deficiency.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dysarthria</b></td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Speech &#x00026; language therapy</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider alternative communication methods as needed (e.g., writing pads &#x00026; digital devices).</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dysphagia</b></td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Modify food consistency to reduce aspiration risk.</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Video esophagram may help define best consistency.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Poor weight gain</b></td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nutrition assessment</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider nutritional &#x00026; vitamin supplementation to meet dietary needs.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Scoliosis / Skeletal involvement</b></td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgical treatment</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to orthopedic surgeon when required.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cognitive/</b><br /><b>Psychiatric</b></td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pharmacologic treatment</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment for psychiatric manifestations (e.g., depression, anxiety, &#x00026; psychosis)</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Psychotherapy / neuropsychological rehabilitation</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider cognitive &#x00026; behavioral therapy, including Goal Management Training.&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ADL = activities of daily living; OT = occupational therapy/therapist; PT = physical therapy/therapist</p></div></dd><dt>1. </dt><dd><div id="syne1ca-ar.TF.5.1"><p class="no_margin"><a class="bk_pop" href="#syne1ca-ar.REF.martineau.2014.300">Martineau et al [2014]</a></p></div></dd><dt>2. </dt><dd><div id="syne1ca-ar.TF.5.2"><p class="no_margin"><a class="bk_pop" href="#syne1ca-ar.REF.zesiewicz.2018.464">Zesiewicz et al [2018]</a></p></div></dd><dt>3. </dt><dd><div id="syne1ca-ar.TF.5.3"><p class="no_margin"><a class="bk_pop" href="#syne1ca-ar.REF.van_de_warrenburg.2014.552">van de Warrenburg et al [2014]</a></p></div></dd><dt>4. </dt><dd><div id="syne1ca-ar.TF.5.4"><p class="no_margin"><a class="bk_pop" href="#syne1ca-ar.REF.ruffieux.2017.180">Ruffieux et al [2017]</a></p></div></dd></dl></div></div></div><div id="syne1ca-ar.T.treatment_of_manifestations_1" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with SYNE1-Deficient Arthrogryposis Multiplex Congenita</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1379/table/syne1ca-ar.T.treatment_of_manifestations_1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__syne1ca-ar.T.treatment_of_manifestations_1_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation</th><th id="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multidisciplinary neuromuscular clinic, physiatry, OT/PT</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Maximize gross motor &#x00026; fine motor skills through PT/OT &#x00026; use of adaptive devices. Alternative casting/splinting &#x00026; stretching.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Orthopedics</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manage contractures, clubfoot, &#x00026; scoliosis w/bracing &#x00026;/or surgical intervention.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding/Dysphagia</b></td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gastroenterology / nutrition / feeding team</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Modify food consistency to reduce aspiration risk &#x00026;/or consider NG feeding &#x00026; gastrostomy.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Speech</b></td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Speech/language evaluation</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider involving speech therapist &#x00026; OT to improve communication skills.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manage pulmonary complications; treat respiratory infections.</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurodevelopmental</b></td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early intervention / individual education program based on needs</td><td headers="hd_h_syne1ca-ar.T.treatment_of_manifestations_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">NG = nasogastric; OT = occupational therapy; PT = physical therapy</p></div></dd><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#syne1ca-ar.REF.haliloglu.2013.1311">Haliloglu &#x00026; Topaloglu [2013]</a></p></div></dd></dl></div></div></div></div><div id="syne1ca-ar.Surveillance"><h3>Surveillance</h3><p>There are no published surveillance guidelines for patients with SYNE1 deficiency or for degenerative ataxias in general.</p><div id="syne1ca-ar.T.recommended_surveillance_fo" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with SYNE1 Deficient Cerebellar Ataxia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1379/table/syne1ca-ar.T.recommended_surveillance_fo/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__syne1ca-ar.T.recommended_surveillance_fo_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Organ System</th><th id="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neurologic assessment for progression of ataxia; UMN or LMN signs</div></li><li class="half_rhythm"><div>Monitor ataxia progression w/standardized scale (SARA, ICARS, or BARS)&#x000a0;<sup>1,&#x000a0;2</sup></div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually; more often for an acute exacerbation</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Physiatry, OT/PT assessment of mobility, self-help skills as they relate to ataxia, spasticity, weakness</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually; more often for an acute exacerbation</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dysarthria</b></td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Need for alternative communication method or speech therapy</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Per symptom progression</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dysphagia</b></td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess aspiration risk &#x00026; feeding methods</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Per symptom progression</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cognitive/</b><br /><b>Psychiatric</b></td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate mood, signs of psychosis, cognitive complaints to identify need for pharmacologic &#x00026; psychotherapeutic interventions.</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Per symptom progression &#x00026; development of psychiatric symptoms</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">LMN = lower motor neuron; OT = occupational therapy; PT = physical therapy; UMN = upper motor neuron</p></div></dd><dt>1. </dt><dd><div id="syne1ca-ar.TF.7.1"><p class="no_margin">SARA = Scale for the Assessment and Rating of Ataxia; ICARS = International Co-operative Ataxia Rating Scale; BARS = Brief Ataxia Rating Scale</p></div></dd><dt>2. </dt><dd><div id="syne1ca-ar.TF.7.2"><p class="no_margin"><a class="bk_pop" href="#syne1ca-ar.REF.b_rk.2018.329">B&#x000fc;rk &#x00026; Sival [2018]</a></p></div></dd></dl></div></div></div><div id="syne1ca-ar.T.recommended_surveillance_fo_1" class="table"><h3><span class="label">Table 8. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with SYNE1-Deficient Arthrogryposis Multiplex Congenita</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1379/table/syne1ca-ar.T.recommended_surveillance_fo_1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__syne1ca-ar.T.recommended_surveillance_fo_1_lrgtbl__"><table><thead><tr><th id="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Organ System</th><th id="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic assessment</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually; more often for an acute exacerbation</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Physiatry, OT/PT assessment of mobility, self-help skills</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually; more often for an acute exacerbation</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for:
<ul><li class="half_rhythm"><div>Progression of kyphoscoliosis</div></li><li class="half_rhythm"><div>Clubfoot relapse</div></li><li class="half_rhythm"><div>Other complications that limit function</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually or more often according to specific complaints</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Speech</b></td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for:
<ul><li class="half_rhythm"><div>Speech &#x00026; language development</div></li><li class="half_rhythm"><div>Need for alternative communication method</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Individualized according to specific needs &#x00026; potential for progression</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Feeding</b></td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess:
<ul><li class="half_rhythm"><div>Aspiration risk</div></li><li class="half_rhythm"><div>Nutritional status</div></li></ul>
</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As neurologic function improves consider advancing food consistency &#x00026; diet.</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Attention to possible respiratory insufficiency</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As needed</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurodevelopmental</b></td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Educational placement &#x00026; school support</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Social/</b><br /><b>Behavioral</b></td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess age-related social/maturation issues.</td><td headers="hd_h_syne1ca-ar.T.recommended_surveillance_fo_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually or more often according to specific needs</td></tr></tbody></table></div></div></div><div id="syne1ca-ar.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#syne1ca-ar.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="syne1ca-ar.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="syne1ca-ar.Genetic_Counseling"><h2 id="_syne1ca-ar_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="syne1ca-ar.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>SYNE1 deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="syne1ca-ar.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>SYNE1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with SYNE1 deficiency are obligate heterozygotes (carriers) for a <i>SYNE1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>SYNE1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="syne1ca-ar.Carrier_Heterozygote_Detectio"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>SYNE1</i> pathogenic variants in the family.</p></div><div id="syne1ca-ar.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="syne1ca-ar.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SYNE1</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="syne1ca-ar.Resources"><h2 id="_syne1ca-ar_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>AMCSI: Arthrogryposis Multiplex Congenita Suuport, Inc.</b></div><div>P.O. Box 6291</div><div>Spartanburg SC 29304</div><div><b>Phone:</b> 805-55-AMCSI (1-805-552-6274)</div><div><b>Email:</b> bod@amcsupport.org</div><div><a href="https://amcsupport.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.amcsupport.org</a></div></li><li class="half_rhythm"><div><b>Ataxia UK</b></div><div>Lincoln House</div><div>1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> 0845 644 0606 (helpline); 020 7582 1444 (office); +44 (0) 20 7582 1444 (from abroad)</div><div><b>Email:</b> helpline@ataxia.org.uk; office@ataxia.org.uk</div><div><a href="http://www.ataxia.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org.uk</a></div></li><li class="half_rhythm"><div><b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b></div><div>Ataxia UK</div><div>Lincoln House, Kennington Park, 1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 207 582 1444</div><div><b>Email:</b> smillman@ataxia.org.uk</div><div><a href="https://www.euroataxia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euroataxia.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22234/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Spinocerebellar ataxia</a></div></li><li class="half_rhythm"><div><b>Spinocerebellar Ataxia: Making an Informed Choice about Genetic Testing</b></div><div><i>Booklet providing information about Spinocerebellar Ataxia</i></div><div><a href="http://depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf</a></div></li><li class="half_rhythm"><div><b>CoRDS Registry</b></div><div>Sanford Research</div><div>2301 East 60th Street North</div><div>Sioux Falls SD 57104</div><div><b>Phone:</b> 605-312-6423</div><div><b>Email:</b> sanfordresearch@sanfordhealth.org</div><div><a href="http://www.sanfordresearch.org/SpecialPrograms/cords/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CoRDS Registry</a></div></li></ul></div><div id="syne1ca-ar.Molecular_Genetics"><h2 id="_syne1ca-ar_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="syne1ca-ar.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>SYNE1 Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1379/table/syne1ca-ar.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__syne1ca-ar.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_syne1ca-ar.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_syne1ca-ar.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_syne1ca-ar.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_syne1ca-ar.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_syne1ca-ar.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_syne1ca-ar.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_syne1ca-ar.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/23345" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SYNE1</i></a></td><td headers="hd_b_syne1ca-ar.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=23345" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6q25<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_syne1ca-ar.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q8NF91" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Nesprin-1</a></td><td headers="hd_b_syne1ca-ar.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/SYNE1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SYNE1 homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_syne1ca-ar.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SYNE1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SYNE1</a></td><td headers="hd_b_syne1ca-ar.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SYNE1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SYNE1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="syne1ca-ar.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="syne1ca-ar.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for SYNE1 Deficiency (<a href="/omim/608441,610743" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1379/table/syne1ca-ar.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__syne1ca-ar.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608441" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608441</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPECTRIN REPEAT-CONTAINING NUCLEAR ENVELOPE PROTEIN 1; SYNE1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610743" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610743</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8</td></tr></tbody></table></div></div><div id="syne1ca-ar.Molecular_Genetic_Pathogenesi"><h3>Molecular Genetic Pathogenesis</h3><p><b>Gene structure.</b>
<i>SYNE1</i> is one of the largest genes in the human genome with 0.5 Mb of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Alternatively spliced transcript variants encoding different protein <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> have been described. The longest transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_182961.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_182961.3</a> (27,748 bp; variant 1) has 146 exons, of which exons 1 and 2 are noncoding. A shorter transcript variant <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_033071.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_033071.3</a> (27,439 bp; variant 2) has 146 exons with <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 noncoding; this variant has multiple differences in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> but maintains the same reading frame as transcript variant 1.</p><p>See <a href="/books/NBK1379/#syne1ca-ar.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, transcripts, and protein <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>.</p><p><b>Pathogenic variants.</b> Most pathogenic variants associated with the ARCA1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> are <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> or frameshift and are localized throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>, excluding the KASH <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#syne1ca-ar.REF.yoshinaga.2017.17052">Yoshinaga et al 2017</a>]. Pathogenic variants associated with arthrogryposis multiplex congenita (AMC) are distal truncating variants that are expected to lead to a truncated Nesprin1&#x003b1; (or Nesprin1&#x003b1;2) isoform, which is muscle and retina specific [<a class="bk_pop" href="#syne1ca-ar.REF.duong.2014.e94380">Duong et al 2014</a>, <a class="bk_pop" href="#syne1ca-ar.REF.potter.2017">Potter et al 2017</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SYNE1</i> encodes a multi-isomeric protein called nesprin1, a scaffold protein involved in the binding of the nuclear membrane and the cytoskeleton. Nesprin-1 localizes at the outer nuclear membrane, where it interacts with SUN proteins located at the inner nuclear membrane to form the linker of the nucleoskeleton and cytoskeleton (LINC) complex [<a class="bk_pop" href="#syne1ca-ar.REF.sosa.2012.1035">Sosa et al 2012</a>]. The longest transcript variant <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_182961.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_182961.3</a> encodes a 8,797-amino-acid protein (&#x0003e;1000 kd) known as the nesprin-1 giant isoform (Nes1g or isoform-1 or enaptin) (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_892006.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_892006.3</a>) [<a class="bk_pop" href="#syne1ca-ar.REF.groslouis.2007.80">Gros-Louis et al 2007</a>]. The nesprin-1 giant protein contains two N-terminal paired calponin homology domains that bind cytoskeletal actin, a transmembrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, multiple spectrin repeats that mediate anchoring and interaction with other proteins and organelles, and a C-terminal KASH domain that localizes the protein to the nuclear envelope. Transcript variant <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_033071.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_033071.3</a> encodes an 8,749-amino-acid protein known as KLNes1g (or nesprin-1 isoform 2) (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_149062.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_149062.1</a>) [<a class="bk_pop" href="#syne1ca-ar.REF.razafsky.2015.57">Razafsky &#x00026; Hodzic 2015</a>]. The shorter KLNes1g isoform lacks the C-terminal KASH domain.</p><p>Two <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> of the proteins are specifically expressed in the central nervous system when compared with other isoforms and with the related Nesprin2 protein: Nes1g is particularly expressed in CNS tissues along with its KLNes1g, which is abundantly expressed in the cerebellum [<a class="bk_pop" href="#syne1ca-ar.REF.groslouis.2007.80">Gros-Louis et al 2007</a>, <a class="bk_pop" href="#syne1ca-ar.REF.duong.2014.e94380">Duong et al 2014</a>, <a class="bk_pop" href="#syne1ca-ar.REF.razafsky.2015.57">Razafsky &#x00026; Hodzic 2015</a>].</p><p><i>SYNE1</i> has multiple alternative start and termination sites that allow for multiple <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a> lacking certain specific domains [<a class="bk_pop" href="#syne1ca-ar.REF.rajgor.2012.e40098">Rajgor et al 2012</a>; see also <a class="bk_pop" href="#syne1ca-ar.REF.razafsky.2015.57">Razafsky &#x00026; Hodzic 2015</a>, <a class="bk_pop" href="#syne1ca-ar.REF.yoshinaga.2017.17052">Yoshinaga et al 2017</a>, <a class="bk_pop" href="#syne1ca-ar.REF.potter.2018.82">Potter et al 2018</a>, and references therein]. These isoforms are present in multiple subcellular locations beyond the nuclear envelope and serve to link these structures to the actin skeleton [<a class="bk_pop" href="#syne1ca-ar.REF.zhang.2007.2816">Zhang et al 2007</a>]. Specific isoforms appear to have a tissue-specific transcription, and this transcription is highly adaptable according to cell needs for maintaining homeostasis [<a class="bk_pop" href="#syne1ca-ar.REF.rajgor.2012.e40098">Rajgor et al 2012</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most pathogenic variants associated with the ARCA1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> are <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> or frameshift and are localized throughout the gene, excluding the KASH <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#syne1ca-ar.REF.yoshinaga.2017.17052">Yoshinaga et al 2017</a>]. Hence, these pathogenic variants are expected to affect the structure of the KLNes1g isoform, whose loss of function is thought to lead to ARCA1 [<a class="bk_pop" href="#syne1ca-ar.REF.razafsky.2015.57">Razafsky &#x00026; Hodzic 2015</a>]. Indeed, the KLNes1g isoform is abundantly expressed in the cerebellum, where it localizes to essential synapses between mossy fibers and cerebellar granule neurons within the granule cell layer [<a class="bk_pop" href="#syne1ca-ar.REF.potter.2018.82">Potter et al 2018</a>]. Analyses in murine models suggest that this isoform is involved in vesicular trafficking and dendritic membrane structural organization, which indicates that defective synaptic transmission may underlie ARCA1 pathology; however, this remains to be confirmed [<a class="bk_pop" href="#syne1ca-ar.REF.razafsky.2015.57">Razafsky &#x00026; Hodzic 2015</a>]. Pathogenic variants that alter the more C-terminal region of the protein have the potential to also alter the ubiquitously expressed Nesprin1&#x003b2; isoform, which may underlie the more complex multisystem phenotype observed in some patients [<a class="bk_pop" href="#syne1ca-ar.REF.potter.2018.82">Potter et al 2018</a>].</p><p>Pathogenic variants associated with arthrogryposis multiplex congenita (AMC) are distal truncating variants that are expected to lead to a truncated Nesprin1&#x003b1; (or Nesprin1&#x003b1;2) isoform, which is muscle and retina specific [<a class="bk_pop" href="#syne1ca-ar.REF.duong.2014.e94380">Duong et al 2014</a>, <a class="bk_pop" href="#syne1ca-ar.REF.potter.2017">Potter et al 2017</a>]. There is mounting evidence that Nesprin1&#x003b1; is involved in skeletal muscle function: Nesprin1&#x003b1; is upregulated during myogenic differentiation and is required for the recruitment of centrosomal proteins to the nuclear envelope, which ensures proper nuclear positioning [<a class="bk_pop" href="#syne1ca-ar.REF.gimpel.2017">Gimpel et al 2017</a>]. Aberrant nuclear positioning is associated with other muscular diseases, suggesting that proper nuclear localization is essential for skeletal muscle function [<a class="bk_pop" href="#syne1ca-ar.REF.stroud.2017.1915">Stroud et al 2017</a>]. In murine studies of different Nesprin1 <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>, loss of Nesprin1&#x003b1;2 led to severe nuclear mispositioning and postnatal lethality, suggesting that this is the isoform essential for skeletal muscle function [<a class="bk_pop" href="#syne1ca-ar.REF.stroud.2017.1915">Stroud et al 2017</a>]. Hence, loss of the Nesprin1&#x003b1; isoform may underlie muscular involvement in SYNE1 deficiency.</p><p>All <i>SYNE1</i> pathogenic variants would also affect the Nesprin1 giant (Nes1g) isoform, which is predominantly expressed in the central nervous system at the nuclear envelope of Bergmann glia and at ciliary rootlets of ependymal cells [<a class="bk_pop" href="#syne1ca-ar.REF.baumann.2017.262">Baumann et al 2017</a>, <a class="bk_pop" href="#syne1ca-ar.REF.potter.2018.82">Potter et al 2018</a>]. Mouse models with loss of Nes1g did not show any cerebellar <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> but presented ventricular enlargement potentially reflecting cilia dysfunction [<a class="bk_pop" href="#syne1ca-ar.REF.potter.2018.82">Potter et al 2018</a>]. Of interest, scoliosis, respiratory insufficiency, and cognitive impairment are all clinical findings that have been reported in association with other ciliopathies, suggesting that loss of the Nes1g isoform may underlie some non-cerebellar and non-muscular features of the phenotype [<a class="bk_pop" href="#syne1ca-ar.REF.potter.2018.82">Potter et al 2018</a>].</p></div></div><div id="syne1ca-ar.References"><h2 id="_syne1ca-ar_References_">References</h2><div id="syne1ca-ar.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.algahtani.2017.97">Algahtani H, Marzouk Y, Algahtani R, Salman S, Shirah B. Autosomal recessive cerebellar ataxia type 1 mimicking multiple sclerosis: a report of two siblings with a novel mutation in SYNE1 gene in a Saudi family. <span><span class="ref-journal">J Neurol Sci. </span>2017;<span class="ref-vol">372</span>:97–100.</span> [<a href="/pubmed/28017257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28017257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.attali.2009.3462">Attali R, Warwar N, Israel A, Gurt I, McNally E, Puckelwartz M, Glick B, Nevo Y, Ben-Neriah Z, Melki J. Mutation of SYNE-1, encoding an essential component of the nuclear lamina, is responsible for autosomal recessive arthrogryposis. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:3462–9.</span> [<a href="/pubmed/19542096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19542096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.baumann.2017.262">Baumann M, Steichen-Gersdorf E, Krabichler B, Petersen BS, Weber U, Schmidt WM, Zschocke J, M&#x000fc;ller T, Bittner RE, Janecke AR. Homozygous SYNE1 mutation causes congenital onset of muscular weakness with distal arthrogryposis: a genotype-phenotype correlation. <span><span class="ref-journal">Eur J Hum Genet. </span>2017;<span class="ref-vol">25</span>:262–6.</span> [<a href="/pmc/articles/PMC5255944/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5255944</span></a>] [<a href="/pubmed/27782104" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27782104</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.b_rk.2018.329">B&#x000fc;rk K, Sival DA. Scales for the clinical evaluation of cerebellar disorders. <span><span class="ref-journal">Handb Clin Neurol. </span>2018;<span class="ref-vol">154</span>:329–39.</span> [<a href="/pubmed/29903450" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29903450</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.chen.2017.63">Chen Z, Ren Z, Mei W, Ma Q, Shi Y, Zhang Y, Li S, Xiang L, Zhang J. A novel SYNE1 gene mutation in a Chinese family of Emery-Dreifuss muscular dystrophy-like. <span><span class="ref-journal">BMC Med Genet. </span>2017;<span class="ref-vol">18</span>:63.</span> [<a href="/pmc/articles/PMC5460548/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5460548</span></a>] [<a href="/pubmed/28583108" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28583108</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.coutelier.2018.591">Coutelier M, Hammer MB, Stevanin G, Monin ML, Davoine CS, Mochel F, Labauge P, Ewenczyk C, Ding J, Gibbs JR, Hannequin D, Melki J, Toutain A, Laugel V, Forlani S, Charles P, Broussolle E, Thobois S, Afenjar A, Anheim M, Calvas P, Castelnovo G, de Broucker T, Vidailhet M, Moulignier A, Ghnassia RT, Tallaksen C, Mignot C, Goizet C, Le Ber I, Ollagnon-Roman E, Pouget J, Brice A, Singleton A, Durr A, et al.  Efficacy of exome-targeted capture sequencing to detect mutations in known cerebellar ataxia genes. <span><span class="ref-journal">JAMA Neurol. </span>2018;<span class="ref-vol">75</span>:591–9.</span> [<a href="/pmc/articles/PMC5885259/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5885259</span></a>] [<a href="/pubmed/29482223" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29482223</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.duong.2014.e94380">Duong NT, Morris GE, Lam LT, Zhang Q, Sewry CA, Shanahan CM, Holt I. Nesprins: tissue-specific expression of epsilon and other short isoforms. <span><span class="ref-journal">PLoS One. </span>2014;<span class="ref-vol">9</span>:e94380.</span> [<a href="/pmc/articles/PMC3981789/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3981789</span></a>] [<a href="/pubmed/24718612" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24718612</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.dupr_.2007.93">Dupr&#x000e9; N, Gros-Louis F, Chrestian N, Verreault S, Brunet D, de Verteuil D, Brais B, Bouchard JP, Rouleau GA. Clinical and genetic study of autosomal recessive cerebellar ataxia type 1. <span><span class="ref-journal">Ann Neurol. </span>2007;<span class="ref-vol">62</span>:93–8.</span> [<a href="/pubmed/17503513" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17503513</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.gimpel.2017">Gimpel P, Lee YL, Sobota RM, Calvi A, Koullourou V, Patel R, Mamchaoui K, N&#x000e9;d&#x000e9;lec F, Shackleton S, Schmoranzer J, Burke B, Cadot B, Gomes ER. Nesprin-1alpha-dependent microtubule nucleation from the nuclear envelope via Akap450 is necessary for nuclear positioning in muscle cells. Curr Biol. 2017;27:2999-3009 e9. [<a href="/pmc/articles/PMC5640514/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5640514</span></a>] [<a href="/pubmed/28966089" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28966089</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.groslouis.2007.80">Gros-Louis F, Dupr&#x000e9; N, Dion P, Fox MA, Laurent S, Verreault S, Sanes JR, Bouchard JP, Rouleau GA. Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:80–5.</span> [<a href="/pubmed/17159980" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17159980</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.haliloglu.2013.1311">Haliloglu G, Topaloglu H. Arthrogryposis and fetal hypomobility syndrome. <span><span class="ref-journal">Handb Clin Neurol. </span>2013;<span class="ref-vol">113</span>:1311–9.</span> [<a href="/pubmed/23622356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23622356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.hoche.2018.248">Hoche F, Guell X, Vangel MG, Sherman JC, Schmahmann JD. The cerebellar cognitive affective/Schmahmann syndrome scale. <span><span class="ref-journal">Brain. </span>2018;<span class="ref-vol">141</span>:248–70.</span> [<a href="/pmc/articles/PMC5837248/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5837248</span></a>] [<a href="/pubmed/29206893" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29206893</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.izumi.2013.600">Izumi Y, Miyamoto R, Morino H, Yoshizawa A, Nishinaka K, Udaka F, Kameyama M, Maruyama H, Kawakami H. Cerebellar ataxia with SYNE1 mutation accompanying motor neuron disease. <span><span class="ref-journal">Neurology. </span>2013;<span class="ref-vol">80</span>:600–1.</span> [<a href="/pubmed/23325900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23325900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.laforce.2010.443">Laforce R Jr, Buteau JP, Bouchard JP, Rouleau GA, Bouchard RW, Dupr&#x000e9; N. Cognitive impairment in ARCA-1, a newly discovered pure cerebellar ataxia syndrome. <span><span class="ref-journal">Cerebellum. </span>2010;<span class="ref-vol">9</span>:443–53.</span> [<a href="/pubmed/20559786" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20559786</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.mademan.2016.e46">Mademan I, Harmuth F, Giordano I, Timmann D, Magri S, Deconinck T, Claa&#x000df;en J, Jokisch D, Genc G, Di Bella D, Romito S, Sch&#x000fc;le R, Z&#x000fc;chner S, Taroni F, Klockgether T, Sch&#x000f6;ls L, De Jonghe P, Bauer P, Consortium E, Baets J, Synofzik M. Multisystemic SYNE1 ataxia: confirming the high frequency and extending the mutational and phenotypic spectrum. <span><span class="ref-journal">Brain. </span>2016;<span class="ref-vol">139</span>(Pt 8):e46.</span> [<a href="/pmc/articles/PMC4958896/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4958896</span></a>] [<a href="/pubmed/27197992" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27197992</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.martineau.2014.300">Martineau L, Noreau A, Dupr&#x000e9; N. Therapies for ataxias. <span><span class="ref-journal">Curr Treat Options Neurol. </span>2014;<span class="ref-vol">16</span>(7):300.</span> [<a href="/pubmed/24832479" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24832479</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.potter.2018.82">Potter C, Razafsky D, Wozniak D, Casey M, Penrose S, Ge X, Mahjoub MR, Hodzic D. The KASH-containing isoform of Nesprin1 giant associates with ciliary rootlets of ependymal cells. <span><span class="ref-journal">Neurobiol Dis. </span>2018;<span class="ref-vol">115</span>:82–91.</span> [<a href="/pmc/articles/PMC5943178/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5943178</span></a>] [<a href="/pubmed/29630990" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29630990</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.potter.2017">Potter C, Zhu W, Razafsky D, Ruzycki P, Kolesnikov AV, Doggett T, Kefalov VJ, Betleja E, Mahjoub MR, Hodzic D. Multiple isoforms of Nesprin1 are integral components of ciliary rootlets. Curr Biol. 2017;27:2014-22 e6. [<a href="/pmc/articles/PMC5546243/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5546243</span></a>] [<a href="/pubmed/28625779" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28625779</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.rajgor.2012.e40098">Rajgor D, Mellad JA, Autore F, Zhang Q, Shanahan CM. Multiple novel nesprin-1 and nesprin-2 variants act as versatile tissue-specific intracellular scaffolds. <span><span class="ref-journal">PLoS One. </span>2012;<span class="ref-vol">7</span>:e40098.</span> [<a href="/pmc/articles/PMC3388047/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3388047</span></a>] [<a href="/pubmed/22768332" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22768332</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.razafsky.2015.57">Razafsky D, Hodzic D. A variant of Nesprin1 giant devoid of KASH domain underlies the molecular etiology of autosomal recessive cerebellar ataxia type I. <span><span class="ref-journal">Neurobiol Dis. </span>2015;<span class="ref-vol">78</span>:57–67.</span> [<a href="/pmc/articles/PMC4426048/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4426048</span></a>] [<a href="/pubmed/25843669" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25843669</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.rossi.2018.1056">Rossi M, Anheim M, Durr A, Klein C, Koenig M, Synofzik M, Marras C, van de Warrenburg BP, et al.  The genetic nomenclature of recessive cerebellar ataxias. <span><span class="ref-journal">Mov Disord. </span>2018;<span class="ref-vol">33</span>:1056–76.</span> [<a href="/pubmed/29756227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29756227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.ruffieux.2017.180">Ruffieux N, Colombo F, Gentaz E, Annoni JM, Chouiter L, Roulin Hefti S, Ruffieux A, Bihl T. Successful neuropsychological rehabilitation in a patient with cerebellar cognitive affective syndrome. <span><span class="ref-journal">Appl Neuropsychol Child. </span>2017;<span class="ref-vol">6</span>:180–8.</span> [<a href="/pubmed/27049666" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27049666</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.sosa.2012.1035">Sosa BA, Rothballer A, Kutay U, Schwartz TU. LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. <span><span class="ref-journal">Cell. </span>2012;<span class="ref-vol">149</span>:1035–47.</span> [<a href="/pmc/articles/PMC3383001/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3383001</span></a>] [<a href="/pubmed/22632968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22632968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.stroud.2017.1915">Stroud MJ, Feng W, Zhang J, Veevers J, Fang X, Gerace L, Chen J. Nesprin 1alpha2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. <span><span class="ref-journal">J Cell Biol. </span>2017;<span class="ref-vol">216</span>:1915–24.</span> [<a href="/pmc/articles/PMC5496623/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5496623</span></a>] [<a href="/pubmed/28533284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28533284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.sun.2018">Sun M, Johnson AK, Nelakuditi V, Guidugli L, Fischer D, Arndt K, Ma L, Sandford E, Shakkottai V, Boycott K, Chardon JW, Li Z, Del Gaudio D, Burmeister M, Gomez CM, Waggoner DJ, Das S. Targeted exome analysis identifies the genetic basis of disease in over 50% of patients with a wide range of ataxia-related phenotypes. <span><span class="ref-journal">Genet Med. </span>2018.</span> Epub ahead of print. [<a href="/pmc/articles/PMC6524765/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6524765</span></a>] [<a href="/pubmed/29915382" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29915382</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.synofzik.2017.332">Synofzik M, Sch&#x000fc;le R. Overcoming the divide between ataxias and spastic paraplegias: shared phenotypes, genes, and pathways. <span><span class="ref-journal">Mov Disord. </span>2017;<span class="ref-vol">32</span>:332–45.</span> [<a href="/pmc/articles/PMC6287914/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6287914</span></a>] [<a href="/pubmed/28195350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28195350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.synofzik.2016.1378">Synofzik M, Smets K, Mallaret M, Di Bella D, Gallenmuller C, Baets J, Schulze M, Magri S, Sarto E, Mustafa M, Deconinck T, Haack T, Z&#x000fc;chner S, Gonzalez M, Timmann D, Stendel C, Klopstock T, Durr A, Tranchant C, Sturm M, Hamza W, Nanetti L, Mariotti C, Koenig M, Sch&#x000f6;ls L, Sch&#x000fc;le R, de Jonghe P, Anheim M, Taroni F, Bauer P. SYNE1 ataxia is a common recessive ataxia with major non-cerebellar features: a large multi-centre study. <span><span class="ref-journal">Brain. </span>2016;<span class="ref-vol">139</span>:1378–93.</span> [<a href="/pmc/articles/PMC6363274/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6363274</span></a>] [<a href="/pubmed/27086870" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27086870</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.van_de_warrenburg.2014.552">van de Warrenburg BP, van Gaalen J, Boesch S, Burgunder JM, Durr A, Giunti P, Klockgether T, Mariotti C, Pandolfo M, Riess O. EFNS/ENS consensus on the diagnosis and management of chronic ataxias in adulthood. <span><span class="ref-journal">Eur J Neurol. </span>2014;<span class="ref-vol">21</span>:552–62.</span> [<a href="/pubmed/24418350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24418350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.yoshinaga.2017.17052">Yoshinaga T, Nakamura K, Ishikawa M, Yamaguchi T, Takano K, Wakui K, Kosho T, Yoshida K, Fukushima Y, Sekijima Y. A novel frameshift mutation of SYNE1 in a Japanese family with autosomal recessive cerebellar ataxia type 8. <span><span class="ref-journal">Hum Genome Var. </span>2017;<span class="ref-vol">4</span>:17052.</span> [<a href="/pmc/articles/PMC5656760/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5656760</span></a>] [<a href="/pubmed/29081981" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29081981</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.yucesan.2017.2203">Yucesan E, Ugur Iseri SA, Bilgic B, Gormez Z, Bakir Gungor B, Sarac A, Ozdemir O, Sagiroglu M, Gurvit H, Hanagasi H, Ozbek U. SYNE1 related cerebellar ataxia presents with variable phenotypes in a consanguineous family from Turkey. <span><span class="ref-journal">Neurol Sci. </span>2017;<span class="ref-vol">38</span>:2203–7.</span> [<a href="/pubmed/28687974" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28687974</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.zesiewicz.2018.464">Zesiewicz TA, Wilmot G, Kuo SH, Perlman S, Greenstein PE, Ying SH, Ashizawa T, Subramony SH, Schmahmann JD, Figueroa KP, Mizusawa H, Sch&#x000f6;ls L, Shaw JD, Dubinsky RM, Armstrong MJ, Gronseth GS, Sullivan KL. Comprehensive systematic review summary: treatment of cerebellar motor dysfunction and ataxia: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. <span><span class="ref-journal">Neurology. </span>2018;<span class="ref-vol">90</span>:464–71.</span> [<a href="/pmc/articles/PMC5863491/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5863491</span></a>] [<a href="/pubmed/29440566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29440566</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="syne1ca-ar.REF.zhang.2007.2816">Zhang Q, Bethmann C, Worth NF, Davies JD, Wasner C, Feuer A, Ragnauth CD, Yi Q, Mellad JA, Warren DT, Wheeler MA, Ellis JA, Skepper JN, Vorgerd M, Schlotter-Weigel B, Weissberg PL, Roberts RG, Wehnert M, Shanahan CM. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. <span><span class="ref-journal">Hum Mol Genet. </span>2007;<span class="ref-vol">16</span>:2816–33.</span> [<a href="/pubmed/17761684" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17761684</span></a>]</div></li></ul></div></div><div id="syne1ca-ar.Chapter_Notes"><h2 id="_syne1ca-ar_Chapter_Notes_">Chapter Notes</h2><div id="syne1ca-ar.Author_History"><h3>Author History</h3><p>Marie Beaudin, MD (2018-present)<br />Jean-Pierre Bouchard, MD; Laval University (2007-2018)<br />Nicolas Dupr&#x000e9;, MD, MSc (2007-present)<br />Pierre-Luc Gamache, MD, PhD (2018-present)<br />Fran&#x000e7;ois Gros-Louis, PhD (2007-present)<br />Anne Noreau, MD, PhD; University of Montreal (2011-2018)<br />Guy A Rouleau, MD, PhD; University of Montreal (2007-2018)</p></div><div id="syne1ca-ar.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>6 December 2018 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>13 October 2011 (cd) Revision: cognitive changes associated with this disorder as reported by <a class="bk_pop" href="#syne1ca-ar.REF.laforce.2010.443">Laforce et al [2010]</a></div></li><li class="half_rhythm"><div>18 August 2011 (cd) Revision: mutation scanning of select exons and prenatal testing clinically available</div></li><li class="half_rhythm"><div>14 July 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 September 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and <a class="def" href="/books/n/gene/glossary/def-item/targeted-mutation-analysis/">targeted mutation analysis</a> available clinically</div></li><li class="half_rhythm"><div>23 February 2007 (me) Review posted live</div></li><li class="half_rhythm"><div>6 February 2007 (nd) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1379</span><span class="label">PMID: <a href="/pubmed/20301553" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301553</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/suclg1-mtddepl/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/syngap1-id/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1379&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1379/?report=reader">PubReader</a></li><li><a href="/books/NBK1379/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1379" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1379" style="display:none" title="Cite this Page"><div class="bk_tt">Beaudin M, Gamache PL, Gros-Louis F, et al. SYNE1 Deficiency. 2007 Feb 23 [Updated 2018 Dec 6]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1379/pdf/Bookshelf_NBK1379.pdf">PDF version of this page</a> (517K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#syne1ca-ar.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#syne1ca-ar.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#syne1ca-ar.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#syne1ca-ar.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#syne1ca-ar.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#syne1ca-ar.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#syne1ca-ar.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#syne1ca-ar.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#syne1ca-ar.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#syne1ca-ar.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#syne1ca-ar.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#syne1ca-ar.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=23345[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SYNE1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1479650" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1479650" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1479650" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1479650" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30869852" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> FARS2 Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> FARS2 Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Almannai M, Faqeih E, El-Hattab AW, Wong LJC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25299038" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PNPLA6-</i>Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PNPLA6-</i>Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Synofzik M, Hufnagel RB, Züchner S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301468" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sparks SE, Quijano-Roy S, Harper A, Rutkowski A, Gordon E, Hoffman EP, Pegoraro E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27891836" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CLPB Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CLPB Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wortmann SB, Wevers RA, de Brouwer APM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301791" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">POLG</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Cohen BH, Chinnery PF, Copeland WC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301553" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301553" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0416e875f66d18aa66da6e">SYNE1 Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">SYNE1 Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:11:52-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88BDB0E04088D1000000000624024B&amp;ncbi_session=CE88BDB0E0416E71_1572SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1379%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1379&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1379/&amp;ncbi_pagename=SYNE1 Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88BDB0E0416E71_1572SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>